Entry Point
Strategy Diagnostic
Already have a preclinical strategy? We stress-test it. Starting from scratch? We assess what it would take. Either way, you get a clear picture of where your program stands and exactly what to prioritize next.
Two Ways to Use This
The Strategy Diagnostic adapts to where you are. Pick the path that fits.
Gap Analysis
Already have a strategy
You have a preclinical plan, but you want an independent assessment before you commit more runway. We review your current strategy against regulatory expectations, competitive benchmarks, and investor standards, then tell you exactly where the gaps are.
Common at Seed and Series A
Initial Assessment
Starting from discovery
You have promising science but no preclinical plan yet. We assess developability, outline what a preclinical program would require, and give you a plan you can put in front of investors. Sets the foundation for a full Preclinical Roadmap.
Common at Pre-Seed and Spinout
What You Get
A diagnostic deliverable package that gives you clarity on where your program stands and what to do next.
- Study plan with prioritized next studies
- Visual timeline with milestones
- Budget table with quarterly capital requirements
- Risk summary with mitigation recommendations
- Competitive positioning analysis
- Executive summary for board and investor use
Three Diagnostic Dimensions
We scope the right dimensions on the Strategy Call based on where your program needs the most clarity.
Preclinical Readiness
Are you running the right studies with the right models, endpoints, and success criteria? We assess your current plan against regulatory expectations and competitive benchmarks.
Portfolio Prioritization
Which program deserves resources first? We evaluate scientific rationale, competitive positioning, and value-inflection potential to recommend where to focus.
Diligence Readiness
Will your story hold up when investors or partners look closely? We identify gaps in data, narrative, and positioning before the diligence call happens.
Need a Second Opinion on Your Preclinical Plan?
Book a Strategy Call. Complimentary, 30 minutes, no obligation. Whether you need a gap analysis of your existing strategy or an initial assessment from scratch, we will scope the right diagnostic for your situation.
Book a Strategy Call30-minute call · No obligation · Confidential
info@bridgelinetranslational.com · bridgelinetranslational.com